Utility of the ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC beta-lactamases among enterobacteriaceae

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 237-239

  Cantarelli, Vlademir Vicente ^a,b   Inamine, Everton ^a   Brodt, Teresa Cristina Z ^a   Secchi, Carina ^a   Cavalcante, Bianca C ^a   Pereira, Fabiana de Souza ^a  

^a Molecular Biology Section   (Brazil)

^b Feevale Universitary Centre   (Brazil)

Author keywords

AmpC; Cefoxitin screening; Imipenem; Inductible beta lactamases; Screening tests

Indexed keywords

BETA LACTAMASE AMPC; CEFTAZIDIME; IMIPENEM;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CITROBACTER FREUNDII; CONTROLLED STUDY; DRUG ANTAGONISM; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME ANALYSIS; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MORGANELLA MORGANII; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEUS MIRABILIS; SEQUENCE HOMOLOGY;

EID: 34547112270     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000200014     Document Type: Article

References (28)

1. Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
2. Nordmann P. Trends in beta-lactam resistance among Enterobacteriaceae. Clin Infect Dis 1998;27:(Suppl 1)100-6.
3. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-33.
4. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 2002;46:1-11.
5. Barnaud G., Benzerara Y., Gravisse J., et al. Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate. Antimicrob Agents Chemother 2004;48:1040-2.
6. Mammeri H., Poirel L., Bemer P., et. al. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC β-lactamase of a Serratia marcescens clinical isolate. Antimicrob Agents Chemother 2004;48:716-20.
7. Walther-Rasmussen J., Hoiby N. Plasmid-borne AmpC beta-lactamases. Can J Microbiol 2002;48:479-93.
8. Coudron P.E., Moland E.S., Thomson K.S. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000;38:1791-6.
9. Fortineau N., Poirel L., Nordmann P. Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae. J Antimicrob Chemother 2001;47:207-101.
10. Moland E.S., Black J., Ourada. A., et al. Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother 2002;46:3837-42.
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved standard M100-S12. 2002; NCCLS, Wayne, Pa.
12. Black J.A., Thomson K.S., Pitout J.D. Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases. J Clin Microbiol 2004;42:2203-6.
13. Perez-Perez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002;40:2153-62.
14. Lee Y., Lee C.S., Kim Y.J., et al. Development of DNA chip for the simultaneous detection of various beta-lactam antibiotic-resistant genes. Mol. Cells 2002;14:192-7.
15. Sanders C.C. Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu Rev Microbiol 1987;41:573-93.
16. Zhang Y.L., Li J.T., Zhao M.W. Detection of ampC in Enterobacter cloacae in China. Int J Antimicrob Agents 2001;18:365-71.
17. Kirschner P., Meier A. Böttger E.C. Genotypic identification and detection of mycobacteria - facing novel and uncultured pathogens. In: D.H. Persing, T.F. Smith, F.C., Tenover, T.J. White (Eds.), Diagnostic molecular microbiology principles and applications. American Society for Microbiology, Washinton, D.C. 1993.
18. Coudron P.E., Hanson N.D., Climo M.W. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases. J Clin Microbiol 2003;41:772-7.
19. Bret L., Chanal-Claris C., Sirot D., et al. Chromosomally encoded AmpC-type b-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 1998;42:1110-14.
20. Coudron P. E., Moland E. S., Sanders C. C. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol 1997;35:2593-7.
21. Sutcliff J.G. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci USA. 1978;75:3737-41.
22. Rottman M., Benzerara Y., Hanau-Bercot B., et al. Chromosomal ampC genes in Enterobacter species other than Enterobacter cloacae, and ancestral association of the ACT-1 plasmid-encoded cephalosporinase to Enterobacter asburiae. FEMS Microbiol Lett 2002; 210:87-92.
23. Lee S.H., Kim J.Y., Shin S.H., et al. Dissemination of SHV-12 and characterization of new AmpC-type beta-lactamase genes among clinical isolates of Enterobacter species in Korea. J Clin Microbiol 2003;41:2477-82.
24. Poirel L., Guibert M., Girlich D., et al.. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob Agents Chemother 1999; 43:769-76.
25. DHA-1 Gene and Its Regulator Gene ampR, Originated from [i Morganella morganii. Antimicrob Agents Chemother 2000;44:222-5.
26. Livermore D.M., Brown D.F. Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother 2001;48.(Suppl1)59-64.
27. Chow J.W., Fine M.J., Shlaes D.M., et. al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-90.
28. Kaye S. K., Cosgrove S., Harris A., et al., Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 2001;45:2628-30.